How Antibody-Drug Conjugates Have Impacted HER2-Positive Breast Cancer Treatment
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Watch
Imbruvica-Venclexta Combination Demonstrates Benefits in Untreated CLL
Results from a four-year follow-up of a phase 3 trial determined that the combination of Imbruvica and Venclexta provided benefits for untreated patients with CLL.
Read More
Depression Can Impact Breast Cancer Treatment and Survival
Depression reduces the likelihood of receiving recommend treatment, which can affect survival, according to a Kentucky-based study of patients with breast cancer.
